The article reports that Eli Lilly and Co. has obtained a temporary restraining order to halt the launch of Teva Pharmaceuticals' generic Evista in the U.S. Teva indicated that it is preparing to launch the product prior to the resolution of outstanding patent litigation. The medicine will be used for treating and preventing osteoporosis in postmenopausal women. The company is planning to take all appropriate actions needed to protect its intellectual property rights.
Processing Request
No Comments.